Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/allegro-ophthalmics-receives-fda-agreement-under-special-protocol-assessment-spa-for-phase-2b3-clinical-trial-of-risuteganib-for-the-treatment-of-intermediate-dry-amd-301795701.html
https://www.prnewswire.com/news-releases/allegro-ophthalmics-announces-presentation-of-key-data-surrounding-dry-amd-pipeline-candidates-treatment-considerations-301743462.html